• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
A Case Report on Hiccups Improvement With Gabapentin.加巴喷丁改善打嗝的病例报告
Cureus. 2025 Jun 12;17(6):e85849. doi: 10.7759/cureus.85849. eCollection 2025 Jun.
2
Systemic review: the pathogenesis and pharmacological treatment of hiccups.系统评价:呃逆的发病机制和药物治疗。
Aliment Pharmacol Ther. 2015 Nov;42(9):1037-50. doi: 10.1111/apt.13374. Epub 2015 Aug 25.
3
The Black Book of Psychotropic Dosing and Monitoring.《精神药物剂量与监测黑皮书》
Psychopharmacol Bull. 2024 Jul 8;54(3):8-59.
4
Interventions for eye movement disorders due to acquired brain injury.针对后天性脑损伤所致眼球运动障碍的干预措施。
Cochrane Database Syst Rev. 2018 Mar 5;3(3):CD011290. doi: 10.1002/14651858.CD011290.pub2.
5
Antiepileptic drugs for chronic non-cancer pain in children and adolescents.用于儿童和青少年慢性非癌性疼痛的抗癫痫药物。
Cochrane Database Syst Rev. 2017 Aug 5;8(8):CD012536. doi: 10.1002/14651858.CD012536.pub2.
6
Management of urinary stones by experts in stone disease (ESD 2025).结石病专家对尿路结石的管理(2025年结石病专家共识)
Arch Ital Urol Androl. 2025 Jun 30;97(2):14085. doi: 10.4081/aiua.2025.14085.
7
Pharmacologic Interventions for Intractable and Persistent Hiccups: A Systematic Review.顽固性和持续性呃逆的药物干预:一项系统评价
J Emerg Med. 2017 Oct;53(4):540-549. doi: 10.1016/j.jemermed.2017.05.033.
8
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.系统性药理学治疗慢性斑块状银屑病:网络荟萃分析。
Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4.
9
Interventions for treating persistent and intractable hiccups in adults.治疗成人持续性和顽固性呃逆的干预措施。
Cochrane Database Syst Rev. 2013 Jan 31;2013(1):CD008768. doi: 10.1002/14651858.CD008768.pub2.
10
The quantity, quality and findings of network meta-analyses evaluating the effectiveness of GLP-1 RAs for weight loss: a scoping review.评估胰高血糖素样肽-1受体激动剂(GLP-1 RAs)减肥效果的网状Meta分析的数量、质量及结果:一项范围综述
Health Technol Assess. 2025 Jun 25:1-73. doi: 10.3310/SKHT8119.

本文引用的文献

1
Successful Treatment of Persistent Hiccups in an Advanced Palliative Cancer Patient With Gabapentin: A Case Report.加巴喷丁成功治疗晚期姑息性癌症患者的持续性呃逆:一例报告
Cureus. 2023 Mar 31;15(3):e36982. doi: 10.7759/cureus.36982. eCollection 2023 Mar.
2
Intractable Hiccups After Coil Embolization of Partially Thrombosed Posterior Inferior Cerebellar Artery Aneurysm.部分血栓形成的小脑后下动脉动脉瘤弹簧圈栓塞术后顽固性呃逆
World Neurosurg. 2018 Mar;111:251-254. doi: 10.1016/j.wneu.2017.12.118. Epub 2017 Dec 27.
3
Treatment of resistant idiopathic hiccups with pulse radio frequency on phrenic nerve and gabapentin: A case report.膈神经脉冲射频联合加巴喷丁治疗难治性特发性呃逆:一例报告
Niger J Clin Pract. 2017 Jul;20(7):910-913. doi: 10.4103/1119-3077.212438.
4
Chronic Hiccups: An Underestimated Problem.慢性呃逆:一个被低估的问题。
Anesth Analg. 2017 Oct;125(4):1169-1183. doi: 10.1213/ANE.0000000000002289.
5
Review about gabapentin misuse, interactions, contraindications and side effects.加巴喷丁的滥用、相互作用、禁忌证及副作用综述。
J Exp Pharmacol. 2017 Feb 9;9:13-21. doi: 10.2147/JEP.S124391. eCollection 2017.
6
Alphadelta ligands, gabapentin, pregabalin and mirogabalin: a review of their clinical pharmacology and therapeutic use.αδ配体、加巴喷丁、普瑞巴林和米罗加巴喷丁:临床药理学与治疗应用综述
Expert Rev Neurother. 2016 Nov;16(11):1263-1277. doi: 10.1080/14737175.2016.1202764. Epub 2016 Jul 7.
7
Systemic review: the pathogenesis and pharmacological treatment of hiccups.系统评价:呃逆的发病机制和药物治疗。
Aliment Pharmacol Ther. 2015 Nov;42(9):1037-50. doi: 10.1111/apt.13374. Epub 2015 Aug 25.
8
Metoclopramide for patients with intractable hiccups: a multicentre, randomised, controlled pilot study.甲氧氯普胺用于顽固性呃逆患者:一项多中心、随机、对照的试点研究。
Intern Med J. 2014 Dec;44(12a):1205-9. doi: 10.1111/imj.12542.
9
Baclofen for stroke patients with persistent hiccups: a randomized, double-blind, placebo-controlled trial.巴氯芬用于治疗持续性呃逆的中风患者:一项随机、双盲、安慰剂对照试验。
Trials. 2014 Jul 22;15:295. doi: 10.1186/1745-6215-15-295.
10
Persistent hiccups (singultus) as the presenting symptom of lateral medullary syndrome.持续性呃逆作为延髓外侧综合征的首发症状。
Indian J Psychol Med. 2014 Jul;36(3):341-3. doi: 10.4103/0253-7176.135397.

加巴喷丁改善打嗝的病例报告

A Case Report on Hiccups Improvement With Gabapentin.

作者信息

Bahathiq Ali, Abbas Marwah, Al Fareh Nojoud A

机构信息

Psychiatry, King Saud University, Riyadh, SAU.

Psychiatry, King Khalid University Hospital, Riyadh, SAU.

出版信息

Cureus. 2025 Jun 12;17(6):e85849. doi: 10.7759/cureus.85849. eCollection 2025 Jun.

DOI:10.7759/cureus.85849
PMID:40656353
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12255273/
Abstract

Hiccups, or Singultus, are a common condition among individuals. Several medications are under research for hiccup management, including Gabapentin, an analog of the neurotransmitter γ-aminobutyric acid (GABA), which has shown effective outcomes in patients with persistent hiccups, highlighting the need for larger clinical studies to evaluate their efficacy and safety. Despite that, Gabapentin works on the α-2-δ subunit of calcium channels, mediating its effect. Like many hiccup treatments, the exact mechanism through which Gabapentin alleviates hiccups is not fully understood. This case reports an 87-year-old male with a 40-year history of chronic hiccups, unresponsive to traditional psychiatric treatments, including chlorpromazine and haloperidol. The patient began escitalopram 20 mg daily for low mood and later added gabapentin 300 mg three times a day, which significantly improved his hiccups to under 15 minutes daily without any side effects. This case highlights the efficacy and safety of Gabapentin as an effective and well-tolerated treatment for persistent hiccups of unknown cause.

摘要

打嗝,即呃逆,是一种常见的症状。目前正在研究多种用于治疗打嗝的药物,包括加巴喷丁,它是神经递质γ-氨基丁酸(GABA)的类似物,已在持续性打嗝患者中显示出有效结果,这凸显了开展更大规模临床研究以评估其疗效和安全性的必要性。尽管如此,加巴喷丁作用于钙通道的α-2-δ亚基来介导其效应。与许多打嗝治疗方法一样,加巴喷丁缓解打嗝的确切机制尚未完全明确。本病例报告了一名87岁男性,有40年慢性打嗝病史,对包括氯丙嗪和氟哌啶醇在内的传统精神科治疗均无反应。该患者因情绪低落开始每日服用20毫克艾司西酞普兰,后来添加了每日三次每次300毫克的加巴喷丁,这使其打嗝次数显著减少至每天不到15分钟,且无任何副作用。本病例突出了加巴喷丁作为一种治疗不明原因持续性打嗝的有效且耐受性良好的药物的疗效和安全性。